|4Sep 12, 11:34 AM ET

Frelick Jeff 4

4 · Bone Biologics Corp · Filed Sep 12, 2023

Insider Transaction Report

Form 4
Period: 2023-09-11
Frelick Jeff
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2023-09-11$0.69/sh+9,500$6,53017,204 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    ownership.xmlPrimary